Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long‐term favorable response to non‐surgical anti‐cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery

Abstract

Adjuvant surgery for initially unresectable pancreatic cancer patients can be a safe and effective treatment. The overall survival rate from the initial treatment is extremely high, especially in patients who received non-surgical anti-cancer treatment for more than 240 days.